Clinical Trial Update: Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab [Phase 3]

View source ↗

Summary

Phase 3 extension study assessing long-term safety and efficacy of Apitegromab in spinal muscular atrophy patients who completed prior trials; current status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy
• Spinal Muscular Atrophy Type

Drugs mentioned

• Apitegromab (SRK-015)

Snippet

Sponsor: Scholar Rock, Inc. | Conditions: Spinal Muscular Atrophy, Spinal Muscular Atrophy Type 3 | Phase 3 | Status: ACTIVE_NOT_RECRUITING